bucladesine has been researched along with cyclosporine in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (63.64) | 18.2507 |
2000's | 3 (27.27) | 29.6817 |
2010's | 1 (9.09) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Smyth, MJ | 1 |
Grünbaum, L; Seifert, R; Wenzel-Seifert, K | 1 |
Mehta, BA; Negrin, RS; Schmidt-Wolf, IG; Weissman, IL | 1 |
Seifert, R; Wenzel-Seifert, K | 1 |
Handschumacher, RE; Li, W | 1 |
Ernst, M; Funk, JO; Schönharting, MM; Zabel, P | 1 |
Kidokoro, Y; Kuromi, H | 1 |
Fong, CW; Lin, SC; Neo, SY; Zhang, Y | 1 |
Madsen, SS; Tipsmark, CK | 1 |
Cho, CS; Cho, ML; Kim, HY; Kim, WU; Lee, SH; Min, DJ; Min, JK; Min, SY; Park, SH | 1 |
11 other study(ies) available for bucladesine and cyclosporine
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mechanisms of cytotoxicity used by human peripheral blood T-cell subsets.
Topics: Bucladesine; CD4 Antigens; CD8 Antigens; Cholera Toxin; Cycloheximide; Cyclosporine; Cytotoxicity, Immunologic; Dactinomycin; Egtazic Acid; Emetine; Humans; Lymphocyte Activation; Mitomycin; T-Lymphocyte Subsets; Tumor Necrosis Factor-alpha | 1992 |
Differential inhibition of human neutrophil activation by cyclosporins A, D, and H. Cyclosporin H is a potent and effective inhibitor of formyl peptide-induced superoxide formation.
Topics: Bucladesine; Calcium; Cell Aggregation; Cell Differentiation; Complement C5a; Cyclosporine; Cyclosporins; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Glucuronidase; Humans; In Vitro Techniques; Muramidase; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Receptors, Formyl Peptide; Receptors, Immunologic; Superoxides; Time Factors; Tumor Cells, Cultured | 1991 |
Two pathways of exocytosis of cytoplasmic granule contents and target cell killing by cytokine-induced CD3+ CD56+ killer cells.
Topics: Biomarkers; Bucladesine; CD3 Complex; CD56 Antigen; Cell Line, Transformed; Cyclic AMP; Cyclosporine; Cytokines; Cytoplasmic Granules; Cytotoxicity, Immunologic; Exocytosis; Granzymes; Humans; Killer Cells, Natural; Lymphocyte Activation; Lymphocyte Subsets; Lymphoma, B-Cell; Muromonab-CD3; Neoplasm Proteins; Serine Endopeptidases; Signal Transduction; Tacrolimus; Tumor Cells, Cultured | 1995 |
Cyclosporin H is a potent and selective formyl peptide receptor antagonist. Comparison with N-t-butoxycarbonyl-L-phenylalanyl-L-leucyl-L-phenylalanyl-L- leucyl-L-phenylalanine and cyclosporins A, B, C, D, and E.
Topics: Amino Acid Sequence; Bucladesine; Cell Differentiation; Cell Membrane; Cyclosporine; Cyclosporins; Glucuronidase; Humans; In Vitro Techniques; Molecular Sequence Data; N-Formylmethionine Leucyl-Phenylalanine; Oligopeptides; Receptors, Formyl Peptide; Receptors, Immunologic; Superoxides; Tumor Cells, Cultured | 1993 |
Regulation of the nuclear factor of activated T cells in stably transfected Jurkat cell clones.
Topics: Alkaline Phosphatase; Bucladesine; Clone Cells; Colforsin; Cyclosporine; Dinoprostone; DNA-Binding Proteins; Enzyme Inhibitors; Ethers, Cyclic; Female; Humans; Immunosuppressive Agents; Kinetics; Lymphocyte Activation; Marine Toxins; NFATC Transcription Factors; Nuclear Proteins; Okadaic Acid; Oxazoles; Phosphoprotein Phosphatases; Placenta; Pregnancy; Protein Phosphatase 1; Recombinant Proteins; T-Lymphocytes; Tacrolimus; Tetradecanoylphorbol Acetate; Transcription Factors; Transfection; Tumor Cells, Cultured | 1996 |
Pentoxifylline exerts synergistic immunomodulatory effects in combination with dexamethasone or cyclosporin A.
Topics: Adjuvants, Immunologic; Bucladesine; Cells, Cultured; Cyclic AMP; Cyclosporine; Cytokines; Dexamethasone; Drug Combinations; Humans; Lymphocyte Activation; Pentoxifylline; Receptors, Interleukin-2 | 1995 |
The optically determined size of exo/endo cycling vesicle pool correlates with the quantal content at the neuromuscular junction of Drosophila larvae.
Topics: Animals; Axotomy; Bucladesine; Colforsin; Cyclosporine; Cytochalasins; Drosophila melanogaster; Endocytosis; Enzyme Inhibitors; Evoked Potentials; Exocytosis; Fluorescent Dyes; Larva; Mutation; Neuromuscular Junction; Potassium; Presynaptic Terminals; Pyridinium Compounds; Quaternary Ammonium Compounds; Synaptic Vesicles; Temperature; Time Factors | 1999 |
Specific induction of RGS16 (regulator of G-protein signalling 16) mRNA by protein kinase C in CEM leukaemia cells is mediated via tumour necrosis factor alpha in a calcium-sensitive manner.
Topics: Androstadienes; Bucladesine; Calcimycin; Calcineurin; Calcium; Calcium Signaling; Cyclosporine; DNA-Binding Proteins; Egtazic Acid; Enzyme Activation; Humans; Kinetics; Mitogen-Activated Protein Kinases; NFATC Transcription Factors; Nuclear Proteins; Protein Kinase C; Proteins; RGS Proteins; RNA, Messenger; Tacrolimus; Tetradecanoylphorbol Acetate; Thapsigargin; Transcription Factors; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Up-Regulation; Wortmannin | 2000 |
Rapid modulation of Na+/K+-ATPase activity in osmoregulatory tissues of a salmonid fish.
Topics: Animals; Bucladesine; Colforsin; Cyclic AMP; Cyclosporine; Enzyme Inhibitors; Fresh Water; Gills; In Vitro Techniques; Kidney; Okadaic Acid; Ouabain; Phosphodiesterase Inhibitors; Rubidium Radioisotopes; Seawater; Sodium-Potassium-Exchanging ATPase; Theophylline; Trout | 2001 |
Cyclosporine differentially regulates interleukin-10, interleukin-15, and tumor necrosis factor a production by rheumatoid synoviocytes.
Topics: 1-Methyl-3-isobutylxanthine; Antimetabolites; Antirheumatic Agents; Arthritis, Rheumatoid; Bucladesine; Calcineurin Inhibitors; Cells, Cultured; Cyclic AMP; Cyclosporine; Cytokines; Dideoxyadenosine; Fibroblasts; Gene Expression; Humans; Immunosuppressive Agents; Interleukin-10; Interleukin-15; Phosphodiesterase Inhibitors; RNA, Messenger; Synovial Membrane; Tacrolimus; Tumor Necrosis Factor-alpha | 2002 |